Title |
Comparison of reversal of rat pulmonary fibrosis of nintedanib, pirfenidone, and human umbilical mesenchymal stem cells from Wharton’s jelly
|
---|---|
Published in |
Stem Cell Research & Therapy, November 2020
|
DOI | 10.1186/s13287-020-02012-y |
Pubmed ID | |
Authors |
Kuo-An Chu, Chang-Ching Yeh, Fu-Hsien Kuo, Wen-Ren Lin, Chien-Wei Hsu, Tien-Hua Chen, Yu-Show Fu |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Science communicators (journalists, bloggers, editors) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 28 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 3 | 11% |
Researcher | 3 | 11% |
Other | 2 | 7% |
Student > Bachelor | 2 | 7% |
Student > Postgraduate | 2 | 7% |
Other | 3 | 11% |
Unknown | 13 | 46% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 14% |
Biochemistry, Genetics and Molecular Biology | 3 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 7% |
Business, Management and Accounting | 1 | 4% |
Nursing and Health Professions | 1 | 4% |
Other | 5 | 18% |
Unknown | 12 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2020.
All research outputs
#14,996,133
of 23,267,128 outputs
Outputs from Stem Cell Research & Therapy
#1,223
of 2,449 outputs
Outputs of similar age
#285,635
of 508,818 outputs
Outputs of similar age from Stem Cell Research & Therapy
#38
of 89 outputs
Altmetric has tracked 23,267,128 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,449 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 508,818 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.